Review





Similar Products

86
4A Biotech cd41 fitc cd42b pe antibodies
Cd41 Fitc Cd42b Pe Antibodies, supplied by 4A Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc-cd41/anti+cd41+conjugated+fitc/pm41936835-77-9-11
Average 86 stars, based on 1 article reviews
cd41 fitc cd42b pe antibodies - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
Novus Biologicals mouse monoclonal integrin alpha 2b cd41 antibody alexa fluor488 novus nb500 549af488 hip8 fitc mouse
Mouse Monoclonal Integrin Alpha 2b Cd41 Antibody Alexa Fluor488 Novus Nb500 549af488 Hip8 Fitc Mouse, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc-cd41/Integrin+alpha+2b%2FCD41+Antibody+(IVA30)+%5BFITC%5D/pm41923521-76-52-60
Average 94 stars, based on 1 article reviews
mouse monoclonal integrin alpha 2b cd41 antibody alexa fluor488 novus nb500 549af488 hip8 fitc mouse - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

86
4A Biotech fitc conjugated anti cd41
Fitc Conjugated Anti Cd41, supplied by 4A Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc-cd41/anti+cd41+conjugated+fitc/pmc13065674-85-11-16
Average 86 stars, based on 1 article reviews
fitc conjugated anti cd41 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
Elabscience Biotechnology fitc anti mouse cd41 antibody
Fitc Anti Mouse Cd41 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc-cd41/FITC+Anti-Mouse+CD41+Antibody/10__1016_slash_j__cej__2026__175417-180-5-12
Average 94 stars, based on 1 article reviews
fitc anti mouse cd41 antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

86
Fisher Scientific rat anti mouse cd41 fitc conjugated antibodies
( A ) Whole blood cells from freshly drawn citrated human blood were precipitated and washed to deplete fibrinogen, and DPAL was added to cell suspensions at 6 x 10 11 particles/mL, followed by stimulation with thrombin (Thr) and/or convulxin (CVX) in the presence of 2 mM CaCl 2 as indicated. Platelets were identified in a flow cytometer by forward and side scatter, and counterstaining with AlexaFluor ® 488- or AlexaFluor ® 647-conjugated <t>anti-CD41</t> antibodies. (i) Liposome binding was assessed by Cy3 fluorescencein CD41+ platelets, and are shown as percent Cy3-positive (DPAL+) platelets ± S.E.M. (ii) PS exposure was assessed with Annexin V-FITC (AXV) in separate tubes containing aliquots from the treated samples from (i), shown as mean fluorescence intensities (MFI) ± S.E.M. p < 0.01 for all samples compared to unstimulated. ( B ) (i) Platelets as in (A) were stimulated with thrombin with or without 10 μL AXV added as indicated, and DPAL binding is shown as fold change from unstimulated ± S.E.M. (ii) AXV MFI from the samples in (i) are shown ± S.E.M. ( C ) Washed platelets from WT or Ano6 KO mice were suspended in Tyrode’s buffer in the presence of DPAL at 6 x 10 11 particles/mL, stimulated with 0.1 U/mL thrombin as indicated, and assessed for (i) liposome binding as in (B), using FITC-conjugated anti-Cd41 antibodies to identify murine platelets, or (ii) AXV MFI, shown ± S.E.M. ( D ) Human platelets treated as in (A) were counterstained with FITC-conjugated PAC-1; FITC-PAC-1 MFI are shown ± S.E.M. n.s., no significant differences between groups. (E) Aggregation of human platelets suspended in buffer at 2x10 8 platelets/mL, following stimulation with thrombin at the indicated concentrations was measured in the absence (control, CTL) or presence of DPAL added as in (D). Representative of 4 independent experiments. ( F ) Dilute prothrombin time in pooled normal plasma with added rabbit brain tissue thromboplastin, in the presence or absence of DPAL as indicated, and shown as mean ± S.E.M.
Rat Anti Mouse Cd41 Fitc Conjugated Antibodies, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc-cd41/anti+mouse/pmc11725446-60-0-9
Average 86 stars, based on 1 article reviews
rat anti mouse cd41 fitc conjugated antibodies - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

96
Miltenyi Biotec 30f11 1 130 116 535 cd41 fitc
( A ) Whole blood cells from freshly drawn citrated human blood were precipitated and washed to deplete fibrinogen, and DPAL was added to cell suspensions at 6 x 10 11 particles/mL, followed by stimulation with thrombin (Thr) and/or convulxin (CVX) in the presence of 2 mM CaCl 2 as indicated. Platelets were identified in a flow cytometer by forward and side scatter, and counterstaining with AlexaFluor ® 488- or AlexaFluor ® 647-conjugated <t>anti-CD41</t> antibodies. (i) Liposome binding was assessed by Cy3 fluorescencein CD41+ platelets, and are shown as percent Cy3-positive (DPAL+) platelets ± S.E.M. (ii) PS exposure was assessed with Annexin V-FITC (AXV) in separate tubes containing aliquots from the treated samples from (i), shown as mean fluorescence intensities (MFI) ± S.E.M. p < 0.01 for all samples compared to unstimulated. ( B ) (i) Platelets as in (A) were stimulated with thrombin with or without 10 μL AXV added as indicated, and DPAL binding is shown as fold change from unstimulated ± S.E.M. (ii) AXV MFI from the samples in (i) are shown ± S.E.M. ( C ) Washed platelets from WT or Ano6 KO mice were suspended in Tyrode’s buffer in the presence of DPAL at 6 x 10 11 particles/mL, stimulated with 0.1 U/mL thrombin as indicated, and assessed for (i) liposome binding as in (B), using FITC-conjugated anti-Cd41 antibodies to identify murine platelets, or (ii) AXV MFI, shown ± S.E.M. ( D ) Human platelets treated as in (A) were counterstained with FITC-conjugated PAC-1; FITC-PAC-1 MFI are shown ± S.E.M. n.s., no significant differences between groups. (E) Aggregation of human platelets suspended in buffer at 2x10 8 platelets/mL, following stimulation with thrombin at the indicated concentrations was measured in the absence (control, CTL) or presence of DPAL added as in (D). Representative of 4 independent experiments. ( F ) Dilute prothrombin time in pooled normal plasma with added rabbit brain tissue thromboplastin, in the presence or absence of DPAL as indicated, and shown as mean ± S.E.M.
30f11 1 130 116 535 Cd41 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc-cd41/CD45+Antibody%2C+anti-mouse/pmc12575189__DataSheet1-2-81-79
Average 96 stars, based on 1 article reviews
30f11 1 130 116 535 cd41 fitc - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

93
Bio-Rad mwreg30 mca2245f cd80 fitc
( A ) Whole blood cells from freshly drawn citrated human blood were precipitated and washed to deplete fibrinogen, and DPAL was added to cell suspensions at 6 x 10 11 particles/mL, followed by stimulation with thrombin (Thr) and/or convulxin (CVX) in the presence of 2 mM CaCl 2 as indicated. Platelets were identified in a flow cytometer by forward and side scatter, and counterstaining with AlexaFluor ® 488- or AlexaFluor ® 647-conjugated <t>anti-CD41</t> antibodies. (i) Liposome binding was assessed by Cy3 fluorescencein CD41+ platelets, and are shown as percent Cy3-positive (DPAL+) platelets ± S.E.M. (ii) PS exposure was assessed with Annexin V-FITC (AXV) in separate tubes containing aliquots from the treated samples from (i), shown as mean fluorescence intensities (MFI) ± S.E.M. p < 0.01 for all samples compared to unstimulated. ( B ) (i) Platelets as in (A) were stimulated with thrombin with or without 10 μL AXV added as indicated, and DPAL binding is shown as fold change from unstimulated ± S.E.M. (ii) AXV MFI from the samples in (i) are shown ± S.E.M. ( C ) Washed platelets from WT or Ano6 KO mice were suspended in Tyrode’s buffer in the presence of DPAL at 6 x 10 11 particles/mL, stimulated with 0.1 U/mL thrombin as indicated, and assessed for (i) liposome binding as in (B), using FITC-conjugated anti-Cd41 antibodies to identify murine platelets, or (ii) AXV MFI, shown ± S.E.M. ( D ) Human platelets treated as in (A) were counterstained with FITC-conjugated PAC-1; FITC-PAC-1 MFI are shown ± S.E.M. n.s., no significant differences between groups. (E) Aggregation of human platelets suspended in buffer at 2x10 8 platelets/mL, following stimulation with thrombin at the indicated concentrations was measured in the absence (control, CTL) or presence of DPAL added as in (D). Representative of 4 independent experiments. ( F ) Dilute prothrombin time in pooled normal plasma with added rabbit brain tissue thromboplastin, in the presence or absence of DPAL as indicated, and shown as mean ± S.E.M.
Mwreg30 Mca2245f Cd80 Fitc, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc-cd41/Rat+anti+Mouse+CD41/pmc12575189__DataSheet1-0-58-57
Average 93 stars, based on 1 article reviews
mwreg30 mca2245f cd80 fitc - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
Guangzhou JET Bio-Filtration na+k+-atpase activity assay kit
( A ) Whole blood cells from freshly drawn citrated human blood were precipitated and washed to deplete fibrinogen, and DPAL was added to cell suspensions at 6 x 10 11 particles/mL, followed by stimulation with thrombin (Thr) and/or convulxin (CVX) in the presence of 2 mM CaCl 2 as indicated. Platelets were identified in a flow cytometer by forward and side scatter, and counterstaining with AlexaFluor ® 488- or AlexaFluor ® 647-conjugated <t>anti-CD41</t> antibodies. (i) Liposome binding was assessed by Cy3 fluorescencein CD41+ platelets, and are shown as percent Cy3-positive (DPAL+) platelets ± S.E.M. (ii) PS exposure was assessed with Annexin V-FITC (AXV) in separate tubes containing aliquots from the treated samples from (i), shown as mean fluorescence intensities (MFI) ± S.E.M. p < 0.01 for all samples compared to unstimulated. ( B ) (i) Platelets as in (A) were stimulated with thrombin with or without 10 μL AXV added as indicated, and DPAL binding is shown as fold change from unstimulated ± S.E.M. (ii) AXV MFI from the samples in (i) are shown ± S.E.M. ( C ) Washed platelets from WT or Ano6 KO mice were suspended in Tyrode’s buffer in the presence of DPAL at 6 x 10 11 particles/mL, stimulated with 0.1 U/mL thrombin as indicated, and assessed for (i) liposome binding as in (B), using FITC-conjugated anti-Cd41 antibodies to identify murine platelets, or (ii) AXV MFI, shown ± S.E.M. ( D ) Human platelets treated as in (A) were counterstained with FITC-conjugated PAC-1; FITC-PAC-1 MFI are shown ± S.E.M. n.s., no significant differences between groups. (E) Aggregation of human platelets suspended in buffer at 2x10 8 platelets/mL, following stimulation with thrombin at the indicated concentrations was measured in the absence (control, CTL) or presence of DPAL added as in (D). Representative of 4 independent experiments. ( F ) Dilute prothrombin time in pooled normal plasma with added rabbit brain tissue thromboplastin, in the presence or absence of DPAL as indicated, and shown as mean ± S.E.M.
Na+K+ Atpase Activity Assay Kit, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fitc-cd41/Na%2Bk%2B-ATPase+Activity+Assay+Kit/custom%40e-bc-k539-m%4041055772
Average 94 stars, based on 1 article reviews
na+k+-atpase activity assay kit - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


( A ) Whole blood cells from freshly drawn citrated human blood were precipitated and washed to deplete fibrinogen, and DPAL was added to cell suspensions at 6 x 10 11 particles/mL, followed by stimulation with thrombin (Thr) and/or convulxin (CVX) in the presence of 2 mM CaCl 2 as indicated. Platelets were identified in a flow cytometer by forward and side scatter, and counterstaining with AlexaFluor ® 488- or AlexaFluor ® 647-conjugated anti-CD41 antibodies. (i) Liposome binding was assessed by Cy3 fluorescencein CD41+ platelets, and are shown as percent Cy3-positive (DPAL+) platelets ± S.E.M. (ii) PS exposure was assessed with Annexin V-FITC (AXV) in separate tubes containing aliquots from the treated samples from (i), shown as mean fluorescence intensities (MFI) ± S.E.M. p < 0.01 for all samples compared to unstimulated. ( B ) (i) Platelets as in (A) were stimulated with thrombin with or without 10 μL AXV added as indicated, and DPAL binding is shown as fold change from unstimulated ± S.E.M. (ii) AXV MFI from the samples in (i) are shown ± S.E.M. ( C ) Washed platelets from WT or Ano6 KO mice were suspended in Tyrode’s buffer in the presence of DPAL at 6 x 10 11 particles/mL, stimulated with 0.1 U/mL thrombin as indicated, and assessed for (i) liposome binding as in (B), using FITC-conjugated anti-Cd41 antibodies to identify murine platelets, or (ii) AXV MFI, shown ± S.E.M. ( D ) Human platelets treated as in (A) were counterstained with FITC-conjugated PAC-1; FITC-PAC-1 MFI are shown ± S.E.M. n.s., no significant differences between groups. (E) Aggregation of human platelets suspended in buffer at 2x10 8 platelets/mL, following stimulation with thrombin at the indicated concentrations was measured in the absence (control, CTL) or presence of DPAL added as in (D). Representative of 4 independent experiments. ( F ) Dilute prothrombin time in pooled normal plasma with added rabbit brain tissue thromboplastin, in the presence or absence of DPAL as indicated, and shown as mean ± S.E.M.

Journal: Journal of thrombosis and haemostasis : JTH

Article Title: Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice

doi: 10.1016/j.jtha.2024.10.007

Figure Lengend Snippet: ( A ) Whole blood cells from freshly drawn citrated human blood were precipitated and washed to deplete fibrinogen, and DPAL was added to cell suspensions at 6 x 10 11 particles/mL, followed by stimulation with thrombin (Thr) and/or convulxin (CVX) in the presence of 2 mM CaCl 2 as indicated. Platelets were identified in a flow cytometer by forward and side scatter, and counterstaining with AlexaFluor ® 488- or AlexaFluor ® 647-conjugated anti-CD41 antibodies. (i) Liposome binding was assessed by Cy3 fluorescencein CD41+ platelets, and are shown as percent Cy3-positive (DPAL+) platelets ± S.E.M. (ii) PS exposure was assessed with Annexin V-FITC (AXV) in separate tubes containing aliquots from the treated samples from (i), shown as mean fluorescence intensities (MFI) ± S.E.M. p < 0.01 for all samples compared to unstimulated. ( B ) (i) Platelets as in (A) were stimulated with thrombin with or without 10 μL AXV added as indicated, and DPAL binding is shown as fold change from unstimulated ± S.E.M. (ii) AXV MFI from the samples in (i) are shown ± S.E.M. ( C ) Washed platelets from WT or Ano6 KO mice were suspended in Tyrode’s buffer in the presence of DPAL at 6 x 10 11 particles/mL, stimulated with 0.1 U/mL thrombin as indicated, and assessed for (i) liposome binding as in (B), using FITC-conjugated anti-Cd41 antibodies to identify murine platelets, or (ii) AXV MFI, shown ± S.E.M. ( D ) Human platelets treated as in (A) were counterstained with FITC-conjugated PAC-1; FITC-PAC-1 MFI are shown ± S.E.M. n.s., no significant differences between groups. (E) Aggregation of human platelets suspended in buffer at 2x10 8 platelets/mL, following stimulation with thrombin at the indicated concentrations was measured in the absence (control, CTL) or presence of DPAL added as in (D). Representative of 4 independent experiments. ( F ) Dilute prothrombin time in pooled normal plasma with added rabbit brain tissue thromboplastin, in the presence or absence of DPAL as indicated, and shown as mean ± S.E.M.

Article Snippet: Rat-anti-mouse Cd41 FITC-conjugated antibodies and dry chemicals were from Fisher Scientific (Pittsburgh, PA, USA).

Techniques: Binding Assay, Flow Cytometry, Fluorescence, Control, Clinical Proteomics